Forte Biosciences Ownership | Who Owns Forte Biosciences?
Forte Biosciences Ownership Summary
Forte Biosciences is owned by 15.23% institutional investors, 4.97% insiders, and 79.80% retail investors. Fred alger management is the largest institutional shareholder, holding 13.93% of FBRX shares. Federated Hermes Kaufmann Growth is the top mutual fund, with 8.31% of its assets in Forte Biosciences shares.
FBRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Forte Biosciences | 15.23% | 4.97% | 79.80% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fred alger management | 1.64M | 13.93% | $24.54M |
| Orbimed advisors | 1.20M | 10.19% | $17.95M |
| Federated hermes | 1.77M | 9.92% | $48.15M |
| Tybourne capital management (hk) | 786.65K | 6.70% | $11.80M |
| Cable car capital | 500.00K | 4.26% | $7.50M |
| Sphera funds management | 474.31K | 4.04% | $7.11M |
| Vanguard group | 582.26K | 3.27% | $15.88M |
| Adage capital partners gp | 333.33K | 2.84% | $5.00M |
| Woodline partners lp | 331.99K | 2.83% | $4.98M |
| Ikarian capital | 300.00K | 2.55% | $4.50M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tybourne capital management (hk) | 786.65K | 38.15% | $11.80M |
| Cable car capital | 500.00K | 3.21% | $7.50M |
| Sphera funds management | 474.31K | 1.50% | $7.11M |
| Awm investment company | 236.82K | 0.62% | $6.46M |
| Ikarian capital | 300.00K | 0.45% | $4.50M |
| Orbimed advisors | 1.20M | 0.42% | $17.95M |
| Fred alger management | 1.64M | 0.10% | $24.54M |
| Federated hermes | 1.77M | 0.08% | $48.15M |
| Bvf inc/il | 65.35K | 0.04% | $980.25K |
| Quest partners | 18.80K | 0.03% | $512.78K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 244.40K | 0.00% | 244.40K |
| Federated hermes | 1.77M | 0.08% | 130.14K |
| Morgan stanley | 70.53K | 0.00% | 70.38K |
| Ameriprise financial | 69.89K | 0.00% | 69.89K |
| Goldman sachs group | 68.02K | 0.00% | 68.02K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bml capital management | - | - | -1.76M |
| Bvf inc/il | 65.35K | 0.04% | -522.99K |
| Ikarian capital | 300.00K | 0.45% | -176.44K |
| Adar1 capital management | - | - | -159.26K |
| Heights capital management | - | - | -143.03K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Fmr | 244.40K | 0.00% | 244.40K | $3.67M |
| Ameriprise financial | 69.89K | 0.00% | 69.89K | $1.05B |
| Goldman sachs group | 68.02K | 0.00% | 68.02K | $1.85M |
| State street | 38.10K | - | 38.10K | $571.46K |
| Susquehanna group, llp | 34.34K | - | 34.34K | $18.44K |
Sold Out
| Holder | Change |
|---|---|
| Qube research | -3.00 |
| Jpmorgan chase | -3.00 |
| Loring wolcott & coolidge fiduciary advisors llp/ma | -193.00 |
| Private trust co na | -274.00 |
| Advisor group | -1.08K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 19 | -54.76% | 2,710,133 | -73.80% | 15 | 0.20% | 13 | -51.85% | 3 | -40.00% |
| Sep 30, 2025 | 15 | -54.55% | 3,195,999 | -67.42% | 27 | 0.39% | 11 | -52.17% | 1 | -75.00% |
| Jun 30, 2025 | 7 | -75.86% | 1,313,474 | -73.91% | 11 | 0.59% | 5 | -61.54% | - | -100.00% |
| Mar 31, 2025 | 29 | 11.54% | 5,034,503 | 17.74% | 44 | 0.21% | 13 | -13.33% | 4 | - |
| Dec 31, 2024 | 26 | 13.04% | 4,275,837 | 480.46% | 146 | 9.23% | 15 | 650.00% | 4 | -80.95% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Federated Hermes Kaufmann Growth | 1.04M | 8.31% | 80.68K |
| Federated Hermes Kaufmann R | 1.04M | 8.31% | 80.68K |
| Federated Hermes Kaufmann Small Cap A | 702.40K | 5.61% | 53.94K |
| Federated Hermes Kaufmann Small Cap Grow | 702.40K | 5.61% | 53.94K |
| Alger Small Cap Focus I | 496.06K | 3.96% | - |
| Alger Small Cap Focus Composite | 496.06K | 3.96% | - |
| Vanguard Total Stock Mkt Idx Inv | 393.73K | 3.14% | 15.20K |
| Fidelity Select Biotechnology | 310.96K | 2.48% | - |
| Alger Small Cap Growth B | 157.75K | 1.26% | - |
| Alger Large Cap Growth Composite | 139.47K | 1.11% | -18.54K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 30, 2025 | Riley Antony A | CHIEF FINANCIAL OFFICER | Buy | $254.83K |
| Nov 21, 2024 | Riley Antony A | CHIEF FINANCIAL OFFICER | Buy | $125.00K |
| Dec 18, 2023 | Wagner Paul A. | See Remarks | Buy | $7.53K |
| Dec 13, 2023 | Wagner Paul A. | See Remarks | Buy | $7.35K |
| Dec 14, 2023 | Wagner Paul A. | See Remarks | Buy | $7.20K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | 1 | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
FBRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools